MITHRA: Mobile Mental Health in Community-Based Organizations: A Stepped Care Approach to Women's Mental Health
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2021 - 2021
Project Lead
Dr Krishnamachari Srinivasan and Dr Amritha Bhat
Authors
PIs:Dr Krishnamachari Srinivasan Dr Amritha Bhat Co-Is: Dr Tony D S Raj, Dr Ramakrishna Goud, Dr Pra
Project Status
completed
Project Type
NIH